News
Your source for psychedelic news: research breakthroughs, legal updates, industry developments, and the cultural moment around therapy and access.
Digest
See all
Psychedelic News of the Week
Britons seek psychedelic therapy abroad, an MDMA memoir heads to court, a key psychedelic questionnaire is questioned, and Compass maps…
Psychedelic News of the Week
An LSD drug's third win, magic mushrooms for chronic Lyme, a young man's death that…
Psychedelic News of the Week
New Zealand opens a door and Italy slams one shut, while a quiet study asks…
Insights
See all
Can Psilocybin Change How We Treat Anorexia?
Standard treatment fails up to 30% of people with anorexia. The team behind Imperial College’s psilocybin pilot shares what changed…
Music is The Bridge: MAPS Launches Psychedelic Education Initiative
The Music is the Bridge series explores music and storytelling to introduce new audiences to…
EMDR Therapy in the UK, and How It Compares with Psychedelic Therapy
A clear look at EMDR in the UK: how it actually works, what it costs,…
News
See all
487 Records, 27 Countries. What PsyAccess Reveals About Psychedelic Care in Europe
PsyAccess maps 480+ records across Europe, from licensed ketamine clinics to clinical trial sites. Experts and practitioners explain why it…
The FDA Just Held Its First Hearing on Psychedelic Medicine
Four hours at the FDA made it official: approving a psychedelic is the easy part.…
Locked in Schedule 1. UK and the Psilocybin Question
A recent nationwide poll finds broad support for psilocybin-assisted therapy in the UK. But does…
Science
See all
Can Psychedelic-Assisted Therapy Help With Severe Anxiety?
Which psychedelics actually have evidence for anxiety? We break it down with Floris Wolswijk, founder of research database Blossom.
Can Non-Hallucinogenic Psychoplastogens Deliver the Therapeutic Signal?
Neuroplastogens promise psychedelics' brain-rewiring effects without the trip. But can plasticity alone deliver the therapeutic…
Could Psychedelics Support Healthy Aging and Longevity?
Research into psychedelics for healthy aging is now being backed by millions of pounds.
